ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function.

Courtney Crane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.